Economic Investment Trust Limited (EVT) Fair Value & Analysis
Healthcare · CA · Market cap C$128M
Fair value as of: Jun 24, 2026
From 22 valuation models · updated 5 days ago
Share price −2.2% over the past month.
Price vs Fair Value (12 months)
12‑month range C$17.06 – C$24.03 · fair‑value band C$341.40 – C$925.43 · the C$23.50 price screens below the C$486.95 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Economic Investment Trust Limited (EVT) currently trades at C$23.50, while our model-based Fair Value estimate is C$486.95 — implying the stock looks roughly 1,972.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, Economic Investment Trust Limited generated revenue of C$393M at a net margin of 87.8%. Revenue declined 4.2% year over year. It earns a return on equity of 25.6%. The stock trades on a trailing P/E of 0.5. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Economic Investment Trust Limited is a closed-ended equity mutual fund launched and managed by Burgundy Asset Management Ltd. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the S&P/TSX Composite Index, MSCI World Index, and S&P 500 Index. Economic Investment Trust Limited was formed in January 28, 1927 and is domiciled in Canada.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Economic Investment Trust Limited reported revenue of C$396M in FY2025 versus C$241M in FY2021, a compound +13.2%/yr. Reported net income was C$351M in FY2025, compounding +13.4%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.01 | ¥26.59 | -43% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,863 | ₹1,039 | -44% |
| Zoetis Inc Z1TS34 | R$26.19 | R$26.01 | -1% |
| Hansoh Pharmaceutical Group 3692 | HK$29.58 | HK$18.75 | -37% |
| Divi's Laboratories Limited DIVISLAB | ₹6,788 | ₹2,035 | -70% |
| Swedish Orphan Biovitrum AB SOBI | kr 444.80 | kr 440.64 | -1% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Economic Investment Trust Limited (EVT) undervalued?
What is the fair value of EVT?
What is the quality score of EVT?
What is the revenue of Economic Investment Trust Limited (EVT)?
What is the net profit margin of EVT?
Does Economic Investment Trust Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.